At a glance
The Ovarian Cancer Research Program is funding several awards for ovarian cancer research, including clinical trials, investigator-initiated research, early-career academy awards, and pilot projects. Eligible applicants range from postdoctoral or clinical fellows to independent investigators and assistant professors or higher, depending on the mechanism; the early-career academy awards require applicants to be within a set number of years of their last postdoctoral or fellowship position and to have a mentor. Award sizes and periods range from up to $350,000 total costs over 2 years for Pilot Awards to up to $2.8 million total costs over 4 years for the Clinical Trial Award, with other awards capped between $1.05 million and $1.4 million over 4 years. Some mechanisms require preliminary data, some do not allow clinical trials, and several require a letter of intent or preproposal before full application. The notice does not state any geographic or set-aside restrictions.
What it funds
Official description from grants.gov
Summary: Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investigators (ECIs) in clinical trial research to produce effective treatments and cures for ovarian cancer. The OCCTA, through its Leadership, provides for professional and leadership development of the ECIs to include skills and competencies needed to execute clinical trials, providing intensive mentoring, national networking, collaborations, and a peer group for junior clinical trialists. The OCCTA will bring together established investigators (the Academy Dean and Assistant Dean), established Career Guides (mentors), and a group of ECIs/Scholars to conduct successful, highly productive clinical trials in ovarian cancer. Distinctive Features: Research funded under this FY26 funding opportunity will support translational research and small-scale, early-phase clinical trials in ovarian cancer. Preliminary data are required, however, these data do not necessarily need to be derived from the ovarian cancer research field. The ECI must be within 12 years of their last postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent at the time of full application submission deadline. The ECI must commit no less than 25% effort to this award and/or OCCTA activities for the first two years. The Designated Mentor must be a clinical trialist with a strong record of mentoring and training early-career investigators.
Who can apply
- Unrestricted